← Back to all trials
Recruiting
NCT05631379
Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma
Conditions: Retroperitoneal Sarcoma, Body Composition, Malnutrition, Sarcopenia, Sarcopenic Obesity, Myosteatosis
Sex: All
Ages: 18 Years – N/A
Enrollment: 100
Sponsor: Institute of Oncology Ljubljana
Location: Slovenia
Summary
This is a retrospective, observational study in consecutive patients operated on for primary RPS in the Institute of Oncology Ljubljana (Slovenia) between September 1999 and June 2020.
This study aims to investigate the impact of preoperatively assessed body composition parameters on the perioperative outcomes of patients operated on for primary RPS.
The impact of preoperative malnutrition, sarcopenia, sarcopenic obesity and myosteatosis to the oncologic and postoperative outcome in patients operated on for primary RPS will be examined.
Additionally, the aim is to evaluate the prognostic role of preoperative immune and inflammatory markers (serum albumin level, C-reactive protein, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, high-sensitivity modified Glasgow prognostic score) and prognostic nutritional index in primary RPS patients undergoing surgery.
Patient outcome will be evaluated in terms of overall survival (OS), local-recurrence free survival (LRFS), postoperative intrahospital length of stay, overall and major postoperative morbidity.
Eligibility Criteria
Inclusion Criteria:Patients aged above 18 years oldPatients with primary localized RPS or pelvic sarcoma operated at Surgical Department of Institute of Oncology in LjubljanaExclusion Criteria:Patients with Gastrointestinal Stromal Tumors (GISTs) and Retroperitoneal desmoid-type fibromatosis (DF)Patients with visceral sarcomas (arising from visceral organ i.e., gastrointestinal, and genitourinary tracts sarcoma)Patients with benign retroperitoneal / pelvic tumorsPatients with residual RPS operated at another hospitalPatients with present recurrent, secondary, and metastatic RPSUnable to access patients' data
Source: ClinicalTrials.gov (NCT05631379). StuddyBuddy aggregates publicly available trial information.